Results 7,361-7,380 of 14,090 for speaker:Marc MacSharry
- Written Answers — Department of Health: Medicinal Products Reimbursement (10 Oct 2017)
Marc MacSharry: 436. To ask the Minister for Health if a High Court appeal as set out under section 27 of the Health (Pricing and Supply of Medical Goods) Act 2013 is the only mechanism for a pharmaceutical company to seek reimbursement of a medicine in circumstances in which the HSE has decided not to reimburse the medicine; and if he will make a statement on the matter. [42313/17]
- Written Answers — Department of Health: Medicinal Products Reimbursement (10 Oct 2017)
Marc MacSharry: 437. To ask the Minister for Health his plans to establish an independent review mechanism to review appeals by pharmaceutical companies in circumstances in which the HSE has decided not to reimburse their medicinal products; and if he will make a statement on the matter. [42314/17]
- Written Answers — Department of Health: Medicinal Products Reimbursement (10 Oct 2017)
Marc MacSharry: 438. To ask the Minister for Health the difference in approach taken by Irish and other European assessors of a medicine's clinical and cost effectiveness with regard to treatments for rare disease in circumstances in which certain medicines are readily available in over 22 other European countries but have been refused access here; and if he will make a statement on the matter. [42315/17]
- Written Answers — Department of Health: Medicinal Products Reimbursement (10 Oct 2017)
Marc MacSharry: 439. To ask the Minister for Health the role the US Food and Drug Administration has in assessing a medicine for reimbursement here under the Health (Pricing and Supply of Medical Goods) Act 2013; if a conflicting position between the FDA and the European Medicines Authority has a material role in assessing such medicines; and if he will make a statement on the matter. [42316/17]
- Public Accounts Committee: Business of Committee (5 Oct 2017)
Marc MacSharry: It speaks for itself, but I will refine it if possible. It is not our practice to have the Minister attend, but it should be considered in light of the level of importance attaching. There is an omission. On further consideration, the assistant commissioner for Dublin, Mr. Pat Leahy, could usefully contribute to this discussion. One meeting would do it, but, if possible, we will need the...
- Public Accounts Committee: IDA - Financial Statement 2016 (5 Oct 2017)
Marc MacSharry: I welcome the witnesses. I thank them for the presentation and for all the great work they do. The idea around the programme was that ConnectIreland was the contractee, as it were, and the IDA paid it based on its performance. How much did we pay it?
- Public Accounts Committee: IDA - Financial Statement 2016 (5 Oct 2017)
Marc MacSharry: I apologise that I had to pop out for a short while.
- Public Accounts Committee: IDA - Financial Statement 2016 (5 Oct 2017)
Marc MacSharry: It basically goes around the world and generates leads or generates companies' interest in Ireland, and the IDA assists with that and delivers jobs as a result of their referral. Is that it?
- Public Accounts Committee: IDA - Financial Statement 2016 (5 Oct 2017)
Marc MacSharry: I meant it in a simplified way. How many staff are there in the IDA currently?
- Public Accounts Committee: IDA - Financial Statement 2016 (5 Oct 2017)
Marc MacSharry: How many of those are abroad?
- Public Accounts Committee: IDA - Financial Statement 2016 (5 Oct 2017)
Marc MacSharry: They are over and back.
- Public Accounts Committee: IDA - Financial Statement 2016 (5 Oct 2017)
Marc MacSharry: How many are in New York, for example?
- Public Accounts Committee: IDA - Financial Statement 2016 (5 Oct 2017)
Marc MacSharry: Let us say the IDA has to pay €10,000 a month in rent for an apartment for each of them.
- Public Accounts Committee: IDA - Financial Statement 2016 (5 Oct 2017)
Marc MacSharry: It would not be far off that. Let us say €8,000 to €10,000, which would be the market value over there. Would it be reasonable to ask the question as to what our 15 people are doing? Why do we need ConnectIreland to come up with 500 jobs in the various offices throughout the world? Can we do not do what they do?
- Public Accounts Committee: IDA - Financial Statement 2016 (5 Oct 2017)
Marc MacSharry: Yes.
- Public Accounts Committee: IDA - Financial Statement 2016 (5 Oct 2017)
Marc MacSharry: Why would we need ConnectIreland?
- Public Accounts Committee: IDA - Financial Statement 2016 (5 Oct 2017)
Marc MacSharry: I remember it.
- Public Accounts Committee: IDA - Financial Statement 2016 (5 Oct 2017)
Marc MacSharry: Sorry for interrupting but time is short. From a taxpayer's point of view, why would we pay €160 million to the IDA in taxpayers' funds to do a job and then have to pay €3 million or €4 million to somebody else to do the same job?
- Public Accounts Committee: IDA - Financial Statement 2016 (5 Oct 2017)
Marc MacSharry: ConnectIreland or the IDA?
- Public Accounts Committee: IDA - Financial Statement 2016 (5 Oct 2017)
Marc MacSharry: It has not worked out great.